Dec 27 (Reuters) - Outlook Therapeutics Inc OTLK.O:
OUTLOOK THERAPEUTICS® REPORTS FINANCIAL RESULTS FOR FISCAL YEAR 2024 AND PROVIDES CORPORATE UPDATE
OUTLOOK THERAPEUTICS INC - COMMERCIAL LAUNCH OF LYTENAVA IN UK AND GERMANY EXPECTED H1 2025
Source text: ID:nGNX1FQc8G
Further company coverage: OTLK.O
((Reuters.Briefs@thomsonreuters.com;))